Troy E. Wilson
2018
In 2018, Troy E. Wilson earned a total compensation of $4.7M as President and Chief Executive Officer at Kura Oncology, a 176% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $368,480 |
|---|---|
| Option Awards | $3,794,340 |
| Salary | $526,400 |
| Other | $56,618 |
| Total | $4,745,838 |
Wilson received $3.8M in option awards, accounting for 80% of the total pay in 2018.
Wilson also received $368.5K in non-equity incentive plan, $526.4K in salary and $56.6K in other compensation.
Rankings
In 2018, Troy E. Wilson's compensation ranked 2,167th out of 14,244 executives tracked by ExecPay. In other words, Wilson earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,167 out of 14,244 | 85th |
Division Manufacturing | 785 out of 5,765 | 86th |
Major group Chemicals And Allied Products | 263 out of 2,128 | 88th |
Industry group Drugs | 211 out of 1,817 | 88th |
Industry Pharmaceutical Preparations | 164 out of 1,391 | 88th |
Source: SEC filing on April 29, 2019.
Wilson's colleagues
We found three more compensation records of executives who worked with Troy E. Wilson at Kura Oncology in 2018.